BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 25573060)

  • 1. Akt regulation of Aven contributes to the sensitivity of cancer cells to chemotherapeutic agents.
    Han KY; Hwang JW; Bae GU; Kim SN; Kim YK
    Mol Med Rep; 2015 May; 11(5):3866-71. PubMed ID: 25573060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
    Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
    Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential.
    Melzer IM; Fernández SB; Bösser S; Lohrig K; Lewandrowski U; Wolters D; Kehrloesser S; Brezniceanu ML; Theos AC; Irusta PM; Impens F; Gevaert K; Zörnig M
    Cell Death Differ; 2012 Sep; 19(9):1435-45. PubMed ID: 22388353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL.
    Kutuk O; Temel SG; Tolunay S; Basaga H
    Eur J Cancer; 2010 Sep; 46(13):2494-505. PubMed ID: 20619636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis-inhibitor Aven is downregulated in defective spermatogenesis and a novel estrogen target gene in mammalian testis.
    Laurentino S; Gonçalves J; Cavaco JE; Oliveira PF; Alves MG; de Sousa M; Barros A; Socorro S
    Fertil Steril; 2011 Sep; 96(3):745-50. PubMed ID: 21718987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.
    Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J
    Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
    Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
    Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway.
    Liu W; Furuta E; Shindo K; Watabe M; Xing F; Pandey PR; Okuda H; Pai SK; Murphy LL; Cao D; Mo YY; Kobayashi A; Iiizumi M; Fukuda K; Xia B; Watabe K
    Breast Cancer Res Treat; 2011 Jul; 128(1):57-68. PubMed ID: 20665104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
    Chau BN; Cheng EH; Kerr DA; Hardwick JM
    Mol Cell; 2000 Jul; 6(1):31-40. PubMed ID: 10949025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
    Kim TH; Woo JS; Kim YK; Kim KH
    J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel AVEN-NUTM1 fusion gene in acute myeloid leukemia.
    Yuan L; Chen X; Cao X; Wang F; Zhang Y; Ma X; Cao P; Fang J; Chen J; Zhou X; Wu Q; Nie D; Liu M; Liu H
    Int J Lab Hematol; 2021 Aug; 43(4):O207-O210. PubMed ID: 33755317
    [No Abstract]   [Full Text] [Related]  

  • 14. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
    Choi J; Hwang YK; Sung KW; Kim DH; Yoo KH; Jung HL; Koo HH
    Leuk Res; 2006 Aug; 30(8):1019-25. PubMed ID: 16388850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of antiapoptotic survivin and aven genes in rat heart tissue after traumatic brain injury.
    Ozisik K; Ozisik P; Yildirim E; Misirlioglu M; Tuncer S
    Transplant Proc; 2006 Nov; 38(9):2784-7. PubMed ID: 17112829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
    Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
    Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
    Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
    Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.